pt berlico mulia farma

PT Berlico Mulia Farma (Berlico) is a pharmaceutical company that obtained its CPOB (Good Manufacturing Practice) certification, acquired by Sido Muncul in 2014 as part of a strategy to diversify into the pharmaceutical industry, which is expected to provide benefits to the community and become a government partner in improving national health.

Established in 1976 under the name PT Ita Farma, the company changed its name to PT Berlico Mulia Farma in 1993. Sido Muncul officially acquired Berlico on September 1, 2014.

Berlico’s production activities are conducted on a 7,767 m² facility, equipped with facilities to manufacture liquid formulations (syrups and suspensions), solid formulations (tablets, coated tablets, and capsules), and semi-solid formulations (creams). Additionally, the facility is supported by research and development laboratories, quality control and assurance laboratories, storage warehouses, and a waste treatment system.

Currently, Berlico has produced approximately 90 different products that encompass medicinal products (OTC and ethical), health supplements, and traditional medicines. OTC medicinal product brands marketed include: Anacetine (cough and flu medicine for children), Berlosid (stomach medicine) Daktazol cream (anti-fungal infection), etc. Ethical medicinal product brands marketed include: Inflason (anti-inflammatory), Berlimox (antibiotic), Licodipin 5 and 10 (hypertension medicine), Licoprima suspension (antibiotic), Berloson-N cream (anti-inflammatory dermatosis), etc. The health supplement products include Anabion syrup (multivitamins for children), Suprabion capsules (multivitamins for adults), Licokalk caplets (calcium supplements), Folaxin caplets (folic acid supplements), etc. Meanwhile traditional midicinal products for topical use include Tiga Anak Telon Oil, Tiga Anak Eucalyptus Oil, among others.

Berlico collaborates with National Distributors and Pharmaceutical Wholesalers (PBF) to distribute their products throughout Indonesia.